A Landmark UK-US Pharmaceutical Trade Deal: What It Means for Life Sciences and Patients
An OVID Health article by Ollie George Yesterday the UK Government announced a landmark UK-US pharmaceutical trade deal designed to safeguard medicines access and reinforce the UK’s position as a life sciences superpower. The deal delivers headline commitments that have been widely welcomed by industry: · Zero tariffs on pharmaceutical exports · A reduced VPAG …
